English Section

Poland receives first delivery of J&J's single-dose COVID-19 vaccine

14.04.2021 08:30
Poland has received 120,000 doses of the Johnson & Johnson COVID-19 vaccine in its first delivery from the US drug maker, officials said on Wednesday morning, as the country steps up its inoculation campaign.
Johnson  Johnsons Janssen COVID-19 vaccine.
Johnson & Johnson's Janssen COVID-19 vaccine.Photo: EPA/TIMOTHY D. EASLEY

Two days earlier, a fresh supply of around 870,000 doses of the Pfizer-BioNTech COVID-19 vaccine and a separate shipment of about 88,000 doses of the AstraZeneca shot arrived in the country, according to officials.

Later this week, Poland expects to receive around 204,000 doses of a coronavirus vaccine developed by US pharmaceutical company Moderna, Michał Kuczmierowski, head of the Government Strategic Reserves Agency, has told the media.

In all, around 1.3 million doses of various coronavirus vaccines are expected to reach the country this week, Kuczmierowski said.

Around 6,500 vaccination sites are available to citizens as the country rolls out its COVID-19 inoculation programme, according to the prime minister's top aide, Michał Dworczyk, who is spearheading the drive.

The Polish government this month announced plans to administer the J&J single-dose vaccine to homebound and bedridden citizens.

Dworczyk told reporters last week that over 300,000 single-dose COVID-19 vaccines from Johnson & Johnson were scheduled to be delivered to Poland this month.

Health Minister Adam Niedzielski said last month that Poland had ordered a total of 16 million doses of J&J shots.

The European Union on March 11 approved Johnson & Johnson's single-dose COVID-19 vaccine after a speedy review, raising hopes for stepped-up inoculation across the bloc.

Meanwhile, the European Medicines Agency said on Tuesday it was reviewing cases of rare blood clots in women who had taken Johnson & Johnson's vaccine after US federal health authorities recommended pausing the use of the shot, the Reuters news agency reported.

Johnson & Johnson said it would delay the rollout of the vaccine to Europe, according to Reuters.

(gs/pk)

Source: IAR, PAP, Reuters